JAMA Oncology Author Interviews

JAMA Oncology Author Interviews

Podkast av JAMA Network

Tidsbegrenset tilbud

3 Måneder for 9,00 kr

Deretter 99,00 kr / MånedAvslutt når som helst.

Kom i gang
Phone screen with podimo app open surrounded by emojis

Mer enn 1 million lyttere

Du vil elske Podimo, og du er ikke alene

Rated 4.7 in the App Store

Les mer JAMA Oncology Author Interviews

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Alle episoder

126 Episoder
episode New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance artwork
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD. Related Content: * New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.1285?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

29. mai 2025 - 18 min
episode Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury artwork
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury

Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: * Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0756?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

24. apr. 2025 - 12 min
episode Accelerated Aging in Survivors of Childhood Cancer artwork
Accelerated Aging in Survivors of Childhood Cancer

Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah, MD. Related Content: * Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0236?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * On Accelerated Aging—A Phenomenon in Survivors of Childhood Cancer [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.0130?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

20. mars 2025 - 19 min
episode Academic-Community Partnership and Deaths in Promyelocytic Leukemia artwork
Academic-Community Partnership and Deaths in Promyelocytic Leukemia

Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related Content: * Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.7033?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

27. feb. 2025 - 18 min
episode Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy artwork
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: * Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy [https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.6168?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

30. jan. 2025 - 11 min
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️
Phone screen with podimo app open surrounded by emojis

Rated 4.7 in the App Store

Tidsbegrenset tilbud

3 Måneder for 9,00 kr

Deretter 99,00 kr / MånedAvslutt når som helst.

Eksklusive podkaster

Uten reklame

Gratis podkaster

Lydbøker

20 timer i måneden

Kom i gang

Bare på Podimo

Populære lydbøker